Daniel Greenwald

Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs

Kazuki N. Sugahara, Tambet Teesalu, Priya Karmali et al. · Science · 2010 · 1.1K citations · Full text

Pharmacy, Oncology, Pharmacology +17

Acalabrutinib monotherapy in patients with Waldenström macroglobulinemia: a single-arm, multicentre, phase 2 study

Roger G. Owen, Helen O. McCarthy, Simon Rule et al. · The Lancet Haematology · 2019 · 164 citations · Full text

Medicine, Hematology, Pharmacology +4

Phase 2 study of idelalisib and entospletinib: pneumonitis limits combination therapy in relapsed refractory CLL and NHL

Paul M. Barr, Gene Saylors, Stephen E. Spurgeon et al. · Blood · 2016 · 142 citations

Medicine, Pharmacology, Pharmacotherapy +7

Ublituximab ( <scp>TG</scp> ‐1101), a novel glycoengineered anti‐ <scp>CD</scp> 20 antibody, in combination with ibrutinib is safe and highly active in patients with relapsed and/or refractory chronic lymphocytic leukaemia: results of a phase 2 trial

Jeff P. Sharman, Charles M. Farber, Daruka Mahadevan et al. · British Journal of Haematology · 2016 · 62 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

An Early Oxygen-Dependent Step Is Required for Dexamethasone-Induced Apoptosis of Immature Mouse Thymocytes

Javier F. Torres–Roca, James W. Tung, Daniel Greenwald et al. · The Journal of Immunology · 2000 · 35 citations · Full text

Life Sciences, Cell Biology, Immunology +15